Verified benchmarks, research documentation, and technology overviews demonstrating our platform's capabilities
General Learning Encoder (GLE) powered models for multi-modal biosignal analysis. State-of-the-art accuracy across Type 2 Diabetes (94.67%), Parkinson's/Alzheimer's (91.45%), COVID-19 (86.35%), and EEG consciousness (97.65%). Gold-standard validation methodologies including LOOCV, K-Fold CV, and holdout testing.
Independent verification of our subject-invariant representation model. Our solution achieved 29.1% improvement over baseline—13.5x better than the official winner.
Learn about our General Learning Encoder (GLE) architecture—a universal pre-trained encoder that enables subject-invariant, cross-task generalization for EEG applications.
Verified performance metrics demonstrating our models' superiority over winning solutions from top research competitions.
Our team at Univault Technologies has developed breakthrough AI models for biosignal processing using the General Learning Encoder (GLE). Our work focuses on creating subject-invariant, cross-task generalizable models that work out-of-the-box without per-user calibration.
All benchmarks and verification results are independently verifiable through our open-source repository. We publish these results to demonstrate the scientific rigor and real-world usefulness of our technology for critical applications including mental health screening, cognitive assessment, and consciousness monitoring.